We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Imaging Technique Provides Physicians and Researchers with New Tools

By MedImaging International staff writers
Posted on 12 Sep 2016
Print article
Image: A multi-ciliated cell, as seen in a scanning electron micrograph (SEM) (Photo courtesy of Biomedical Optics Express).
Image: A multi-ciliated cell, as seen in a scanning electron micrograph (SEM) (Photo courtesy of Biomedical Optics Express).
A new optical imaging technique called biophotonics is providing researchers and clinicians with new non-invasive imaging tools to study biological molecules, tissue, and cells.

The technique could be used for cancer imaging and for other diseases, and makes use of infrared, near infrared, visible, and ultraviolet light instead of X-Rays or gamma radiation. The technique can image structures that are too small for X-Ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), and it does not harm the biological cells under investigation.

Biophotonics is expanding the boundaries of radiology and involves multiple medical, scientific, and engineering disciplines. One application of biophotonics is in a cross-sectional microscopic, high-speed, imaging modality called Optical Coherence Tomography (OCT) that is similar to ultrasound in that both use an echo-based paradigm. OCT is used by clinicians to study retina of the eye, and for the diagnosis of macular degeneration and glaucoma. Another modality is called Diffuse Optical Tomography (DOT) that uses near-infrared light for brain, breast, and other soft tissues imaging. The new tools could be also be used for intravascular imaging, the assessment of tumor margins during surgery, image-guided cardiovascular interventions, and the assessment of response to chemotherapy treatment.

Michael A. Choma, MD, PhD, principal investigator at the Yale Biophotonics Laboratory, and assistant professor, Yale University (New Haven, CT, USA), said, “With biophotonics, we can image very small-scale physiology at high-speed resolution. It’s highly complementary to MRI and CT and the technology continues to develop with advances in computing, light sources and cameras. The possibilities are expanding as the people who develop the technology work with the people who use it to improve screening and treatment.”

Related Links:
Yale University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Wireless Handheld Ultrasound System
TE Air
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.